Skip to product information
1 of 1

A Gholamrezanezha

Coronavirus Disease 2019 (Covid-19): A Clinical Gu ide

Coronavirus Disease 2019 (Covid-19): A Clinical Gu ide

Dispatches within 7 to 10 working days
Regular price £88.55 GBP
Regular price £100.00 GBP Sale price £88.55 GBP
11% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £11.45

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Coronavirus Disease 2019 (Covid-19): A Clinical Gu ide


Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides comprehensive coverage of all key aspects of COVID-19, including etiology, diagnosis, symptomatology, management, and treatment. It is an indispensable resource for clinicians, researchers, epidemiologists, nurses, radiologists, and healthcare managers working to address any aspect of the COVID-19 pandemic.

Format: Hardback
Length: 704 pages
Publication date: 12 January 2023
Publisher: John Wiley and Sons Ltd


Coronavirus Disease 2019 (COVID-19) is a highly contagious respiratory illness caused by the SARS-CoV-2 virus. It has rapidly spread worldwide, causing a global pandemic that has impacted millions of lives. This clinical guide provides comprehensive coverage of all key aspects of COVID-19, including its etiology, diagnosis, symptomatology, management, and treatment.

Etiology:

COVID-19 is believed to have originated in Wuhan, China, in late 2019. The virus is highly contagious and spreads primarily through respiratory droplets, particularly when an infected person coughs, sneezes, or talks. It can also spread through contact with contaminated surfaces or objects.

Diagnosis:

Diagnosing COVID-19 involves a combination of clinical symptoms, laboratory tests, and imaging studies. Common symptoms include fever, cough, shortness of breath, fatigue, loss of taste or smell, and body aches. Laboratory tests, such as reverse transcription-polymerase chain reaction (RT-PCR) tests, can detect the presence of the virus's genetic material in respiratory samples. Imaging studies, such as chest CT scans, can help identify lung abnormalities associated with COVID-19.

Symptomatology:

The severity of COVID-19 symptoms can vary widely, ranging from mild to severe. Mild symptoms may include fever, cough, and fatigue, while severe symptoms can lead to respiratory distress, pneumonia, and organ failure. Severe cases are more likely to occur in older individuals, those with underlying medical conditions, and individuals with compromised immune systems.

Management:

The management of COVID-19 primarily involves supportive care and treatment. This includes managing fever and pain with over-the-counter medications, rest, and hydration. In more severe cases, hospitalization may be necessary for oxygen therapy, mechanical ventilation, and other intensive care measures. Medications such as antiviral drugs, corticosteroids, and immunomodulators have been used to treat COVID-19, but their effectiveness and safety are still under investigation.

Treatment:

There is currently no cure for COVID-19, but several treatments have been shown to be effective in reducing the severity and duration of symptoms. These include antiviral drugs such as remdesivir and Pfizer-BioNTech's COVID-19 vaccine. Remdesivir is an antiviral drug that has been shown to reduce the recovery time of infected individuals by up to three days. The COVID-19 vaccine has been shown to be highly effective in preventing severe illness and hospitalization.

Health Policies:

The response to the COVID-19 pandemic has involved a range of health policies and measures. These include lockdowns, social distancing, mask-wearing, and contact tracing. Health policies have been implemented to limit the spread of the virus and protect vulnerable populations.

Mass Casualty Planning:

In the event of a large-scale outbreak, healthcare systems must be prepared to manage mass casualties. This involves developing plans for resource allocation, surge capacity, and communication. Healthcare workers must also be trained in mass casualty management to ensure their safety and the safety of patients.

Healthcare Worker Safety:

Healthcare workers are at high risk of exposure to COVID-19, particularly in healthcare settings. It is essential to provide them with proper protective equipment, training, and support to ensure their safety.

Economic Impact:

The COVID-19 pandemic has had a significant economic impact on societies worldwide. It has led to job losses, business closures, and economic instability. Governments and organizations have implemented economic stimulus packages and support programs to mitigate the impact.

Lessons for Future Outbreaks:

The COVID-19 pandemic has provided valuable lessons for future outbreaks. It has highlighted the importance of early detection, rapid response, and effective communication. It has also highlighted the need for global cooperation and collaboration in responding to public health emergencies.

Para-Clinical and Social Aspects:

COVID-19 has impacted not only the health of individuals but also their social and emotional well-being. It has led to social isolation, anxiety, and depression. It has also highlighted the importance of mental health support and the need for social support programs.

In conclusion, COVID-19 is a highly contagious respiratory illness that has caused a global pandemic. This clinical guide provides comprehensive coverage of all key aspects of COVID-19, including its etiology, diagnosis, symptomatology, management, and treatment. Healthcare professionals at all levels must stay up-to-date with the latest information and guidelines to ensure the best possible care for patients.

Weight: 1826g
Dimension: 258 x 205 x 37 (mm)
ISBN-13: 9781119789680

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details